 |
|
|
|
|
|
 |
Deals & Alliances |
|
|
| Title |
 |
Publication Date |
 |
Price |
|
|
|
|
Bayer Partnering Guide 2008
|
July 2008 |
£195 |
Biogen Idec Partnering Guide 2008
|
July 2008 |
£195 |
Baxter Partnering Guide 2008
|
July 2008 |
£195 |
BMS Partnering Guide 2008
|
July 2008 |
£195 |
AstraZeneca Partnering Guide 2008
|
July 2008 |
£195 |
Boehringer Ingelheim Partnering Guide 2008
|
July 2008 |
£195 |
CSL Partnering Guide 2008
|
July 2008 |
£195 |
Genentech Partnering Guide 2008
|
July 2008 |
£195 |
Forest Partnering Guide 2008
|
July 2008 |
£195 |
Eli Lilly Partnering Guide 2008
|
July 2008 |
£195 |
Eisai Partnering Guide 2008
|
July 2008 |
£195 |
Astellas Partnering Guide 2008
|
July 2008 |
£195 |
Amgen Partnering Guide 2008
|
July 2008 |
£195 |
Daiichi Sankyo Pharma Partnering Guide 2008
|
July 2008 |
£195 |
Menarini Pharma Partnering Guide 2008
|
July 2008 |
£195 |
Chugai Partnering Guide 2008
|
July 2008 |
£195 |
Barr Pharmaceuticals Partnering Guide 2008
|
July 2008 |
£195 |
Actavis Pharma Partnering Guide 2008
|
July 2008 |
£195 |
Mundipharma Partnering Guide 2008
|
July 2008 |
£195 |
Servier Partnering Guide 2008
|
July 2008 |
£195 |
Allergan Partnering Guide 2008
|
July 2008 |
£195 |
Alcon Labs Partnering Guide 2008
|
July 2008 |
£195 |
Abbott Labs Partnering Guide 2008
|
July 2008 |
£195 |
Stada Partnering Guide 2008
|
July 2008 |
£195 |
Genzyme Partnering Guide 2008
|
July 2008 |
£195 |
Ratiopharm Partnering Guide 2008
|
July 2008 |
£195 |
ScheringPlough Partnering Guide 2008
|
July 2008 |
£195 |
Shire Partnering Guide 2008
|
July 2008 |
£195 |
SanofiAventis Partnering Guide 2008
|
July 2008 |
£195 |
Roche Partnering Guide 2008
|
July 2008 |
£195 |
ProcterGamble Partnering Guide 2008
|
July 2008 |
£195 |
Solvay Partnering Guide 2008
|
July 2008 |
£195 |
Takeda Partnering Guide 2008
|
July 2008 |
£195 |
Gilead Partnering Guide 2008
|
July 2008 |
£195 |
Wyeth Partnering Guide 2008
|
July 2008 |
£195 |
Watson Partnering Guide 2008
|
July 2008 |
£195 |
Teva Partnering Guide 2008
|
July 2008 |
£195 |
Pfizer Partnering Guide 2008
|
July 2008 |
£195 |
UCB Partnering Guide 2008
|
July 2008 |
£195 |
Lundbeck Partnering Guide 2008
|
July 2008 |
£195 |
Otsuka Partnering Guide 2008
|
July 2008 |
£195 |
King Partnering Guide 2008
|
July 2008 |
£195 |
Johnson Johnson Partnering Guide 2008
|
July 2008 |
£195 |
Merck Partnering Guide 2008
|
July 2008 |
£195 |
Merck Serono Partnering Guide 2008
|
July 2008 |
£195 |
Nycomed Partnering Guide 2008
|
July 2008 |
£195 |
Novo Nordisk Partnering Guide 2008
|
July 2008 |
£195 |
Novartis Partnering Guide 2008
|
July 2008 |
£195 |
GlaxoSmithKline Partnering Guide 2008
|
July 2008 |
£195 |
Mitsubishi Tanabe Partnering Guide 2008
|
July 2008 |
£195 |
Partnering with Biopharma
The definitive guide to bigpharma partnering interests, contacts & agreements
|
July 2008 |
£1495 |
Clinical Stage Partnering Agreements in Biopharma
|
June 2008 |
£1195 |
Emerging Pharmaceutical Markets Globally
|
April 2008 |
£755 |
Distribution Agreements in Biopharma
|
April 2008 |
£1195 |
Manufacturing & Supply Agreements in Biopharma
|
April 2008 |
£1195 |
Bigpharma Partnering Agreements
|
March 2008 |
£1195 |
NitroMed Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
North American Scientific Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
NexMed Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Neurocrine Biosciences Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Nestle SA -Deals & Alliances Report
|
February 2008 |
£300 |
Neurochem Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Novadel Pharma Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Neurogen Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Novavax, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Nuvelo Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Neose Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Nutrition 21 Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Novozymes A -Deals & Alliances Report
|
February 2008 |
£300 |
Noven Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Novo Nordisk A -Deals & Alliances Report
|
February 2008 |
£300 |
Novartis AG -Deals & Alliances Report
|
February 2008 |
£300 |
Millipore Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Monsanto Co. -Deals & Alliances Report
|
February 2008 |
£300 |
Motorola Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
MultiCell Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Monogram Biosciences, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Mitsui & Co. Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
Nymox Pharmaceutical Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Misonix Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Mylan, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Myriad Genetics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Nektar Therapeutics -Deals & Alliances Report
|
February 2008 |
£300 |
NeoPharm Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Nastech Pharmaceutical Company, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Nanogen Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
NPS Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Nabi Biopharmaceuticals -Deals & Alliances Report
|
February 2008 |
£300 |
Neoprobe Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Pharmaceutical Product Development Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Par Pharmaceutical Companies Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Parexel International Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Penwest Pharmaceuticals Co. -Deals & Alliances Report
|
February 2008 |
£300 |
Panacos Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Pall Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Pacific Biometrics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Palatin Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Peregrine Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
PerkinElmer Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Pharmasset, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Pharming Group N.V. -Deals & Alliances Report
|
February 2008 |
£300 |
Pharmacopeia, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Millennium Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Perrigo Co. -Deals & Alliances Report
|
February 2008 |
£300 |
Pfizer Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
PDL BioPharma Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
PDI Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Onyx Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Opko Health, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Oncothyreon Inc -Deals & Alliances Report
|
February 2008 |
£300 |
Omnicell Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
OSI Systems, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Omnicare Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
OraSure Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Oracle Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Osiris Therapeutics, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Osteotech Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Oscient Pharmaceuticals Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Orthovita Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Orchid Cellmark Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Orthofix International NV -Deals & Alliances Report
|
February 2008 |
£300 |
OSI Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Lexicon Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Introgen Therapeutics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Intuitive Surgical, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Invitrogen Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
InterMune Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Inspire Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Insite Vision Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Insmed Incorporated -Deals & Alliances Report
|
February 2008 |
£300 |
Inyx Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Jazz Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Koninklijke Philips Electronics NV -Deals & Alliances Report
|
February 2008 |
£300 |
Kosan Biosciences Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
King Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Keryx Biopharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Johnson & Johnson -Deals & Alliances Report
|
February 2008 |
£300 |
KV Pharmaceutical Co. -Deals & Alliances Report
|
February 2008 |
£300 |
Inovio Biomedical Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Inhibitex Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Dr. Reddy's Laboratories Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
Eli Lilly & Co. -Deals & Alliances Report
|
February 2008 |
£300 |
Callisto Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Bayer Schering Pharma AG -Deals & Alliances Report
|
February 2008 |
£300 |
3M Co. -Deals & Alliances Report
|
February 2008 |
£300 |
Allscripts Healthcare Solutions Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
IMS Health Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
IRIS International Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Infinity Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Inflazyme Pharmaceuticals Ltd -Deals & Alliances Report
|
February 2008 |
£300 |
InNexus Biotechnology, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Impax Laboratories Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
ISIS Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
ISTA Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Laboratory Corp. of America Holdings -Deals & Alliances Report
|
February 2008 |
£300 |
Lannett Co. Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Medicure Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Mediware Information Systems Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Medtronic Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Medicis Pharmaceutical Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Medicines Co. -Deals & Alliances Report
|
February 2008 |
£300 |
MedcoHealth Solutions Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
MediciNova Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Meldex International Plc -Deals & Alliances Report
|
February 2008 |
£300 |
Mentor Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Micromet, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Microsoft Corporation -Deals & Alliances Report
|
February 2008 |
£300 |
Merit Medical Systems Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Meridian Bioscience Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Merck & Co. Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Merge Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Medarex Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
McKesson Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Life Therapeutics Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
LifeCell Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Pharsight Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Let's Talk Recovery, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Large Scale Biology Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Lescarden Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Lifecore Biomedical Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Ligand Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Masimo Corporation -Deals & Alliances Report
|
February 2008 |
£300 |
Maxygen Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Martek Biosciences Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
MGI Pharma Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Luminex Corporation -Deals & Alliances Report
|
February 2008 |
£300 |
MDS, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Migenix Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Rochester Medical Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Thomson Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Titan Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
TorreyPines Therapeutics, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Third Wave Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Thermogenesis Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Theragenics Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Thermo Fisher Scientific, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Transgenomic Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Trinity Biotech plc -Deals & Alliances Report
|
February 2008 |
£300 |
United Therapeutics Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Unitedhealth Group, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Unilever NV -Deals & Alliances Report
|
February 2008 |
£300 |
Unigene Laboratories Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Tripos Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Tyco International Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
Teva Pharmaceutical Industries Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
Tenet Healthcare Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Sygnis Pharma AG -Deals & Alliances Report
|
February 2008 |
£300 |
Symyx Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
SurModics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
SuperGen Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Stryker Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Sunesis Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Syngenta AG -Deals & Alliances Report
|
February 2008 |
£300 |
Synvista Therapeutics, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Teleflex Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Telik Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Techne Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Taro Pharmaceutical Industries Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
Tapestry Pharmaceuticals -Deals & Alliances Report
|
February 2008 |
£300 |
Targeted Genetics Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Utek Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
VIA Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
West Pharmaceutical Services Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Women First Healthcare Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Wright Medical Group Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
WellPoint Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Watson Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Waters Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
inVentiv Health, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Wyeth -Deals & Alliances Report
|
February 2008 |
£300 |
XOMA Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
Zimmer Holdings Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
ZymoGenetics, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Zila, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
ZOLL Medical Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
XTL Biopharmaceuticals Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
YM BioSciences Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Warner Chilcott Limited -Deals & Alliances Report
|
February 2008 |
£300 |
Volcano Corporation -Deals & Alliances Report
|
February 2008 |
£300 |
Verenium Corporation -Deals & Alliances Report
|
February 2008 |
£300 |
Vermillion, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Ventana Medical Systems Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
VaxGen Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Valeant Pharmaceuticals International -Deals & Alliances Report
|
February 2008 |
£300 |
Varian Medical Systems Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Vernalis plc -Deals & Alliances Report
|
February 2008 |
£300 |
Vertex Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
ViroPharma Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Vital Images Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Viragen Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Vion Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Vical Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
VioQuest Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Strategic Diagnostics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
StemCells Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Repros Therapeutics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
ResMed Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
